LGND
Ligand Pharmaceuticals Incorporated
$161.71
+$1.75(+1.09%)
66
Overall
--
Value
72
Tech
60
Quality
Market Cap
$3.13B
Volume
147.03K
52W Range
$93.58 - $163.34
Target Price
$168.14
EPS Estimates Overview
| Current Quarter | $1.03 | Next Quarter | $1.07 |
| Current Year | $0.25 | Next Year | $4.72 |
| QoQ Growth | +3.9% | YoY Growth | +1788.0% |
| 3Y EPS CAGR | -20.4% | Target Price | $168.14 |
| Consensus | Buy | Upside | +4.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LGND | $161.71 | +1.1% | 147.03K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ligand Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW